Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across cancer, cardiovascular disease and inflammation

          Learn more

        • Cancer
        • Inflammation
        • Cardiovascular
        • Programs
        • Laboratories
        • Diseases
        • Expertises
        • Services and instrumentation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
  • Impact
        • Impact

          Our research develops new diagnostics, treatments and cures for some of the most deadly and debilitating diseases affecting society today

          Learn more

        • Breakthroughs
        • Community and research
        • Real stories
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
        • Ageing
        • Exercise Snack Program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
        • Careers and studies
        • Contact
  • Donate
    Centenary Institute > People > Associate Professor Mathias Francois

Associate Professor Mathias Francois

Head, David Richmond Laboratory for Cardiovascular Development: Gene Regulation and Editing Program

Programs

  • David Richmond Laboratory for Cardiovascular Development: Gene Regulation and Editing Program

Phone number Phone Number +61 2 9565 6100

Email Email m.francois@centenary.org.au

Associate Professor Francois, heads the David Richmond Laboratory for Cardiovascular Development: Gene Regulation and Editing at the Centenary Institute. He leads a research team with a focus on identifying new and innovative therapeutic approaches targeting vascular disease.

His research focuses on the transcriptional control of endothelial cell specification with a major discovery identified a role for Sox18 transcription factor as a molecular switch that controls lymphatic vessel development (lymphangiogenesis) in the embryo and also during cancer metastasis.

Based on this finding, he has developed a novel approach combining developmental genetics, tumour biology and drug discovery to target transcription factors with small molecule inhibitors, peptide mimetic and antibodies with the aim of discovering a new class of anti-angiogenic drugs.

In recognition of his pioneering role in exploring lymphangiogenesis in health and disease he has been awarded 2 NHMRC Career Development Awards to progress his career as a leading scientist in the field of developmental biology.

Themes

  • Cardiovascular

    Cardiovascular

Topics

  • Chronic diseases ,
  • Genetic diseases ,

Publications

Recent publications

Search amongst our repository

all publications

For access to all Publications via Pub Med.

News

  • Research boost for heart muscle disease

    World-leading research into heart muscle disease has been boosted with the Centenary Institute’s Associate Professor Mathias Francois and team awarded a National Health and Medical Research Council (NHMRC) Ideas Grant to investigate left ventricular non compaction cardiomyopathy (LVNC).
    Date 15 Dec 2022
  • New discovery to aid treatment of problem infant hemangiomas

    Research led by the Centenary Institute and the Harvard Medical School, Boston, shows that a compound present in current beta blocker treatments could be repurposed to increase efficiency and safety of infantile hemangioma therapies.
    Date 23 Dec 2021
  • Centenary Institute receives $1.8m in funding for cardiovascular research

    World-leading research into cardiovascular disease has been boosted with three researchers from the Centenary Institute securing Cardiovascular Research Capacity Program grants from the NSW Government.
    Date 24 Nov 2021
  • Meet Associate Professor Mathias Francois

    Associate Professor Mathias Francois established the Centenary Institute’s ‘David Richmond Laboratory for Cardiovascular Development: Gene Regulation and Editing’ back in June 2019. It’s the architecture and complexity of the vascular system in humans that he finds particularly fascinating, especially their mode of assembly during embryonic development.
    Date 04 May 2021
    A/Prof Mathias Francois A/Prof Mathias Francois
View all

Twitter

Tweets by CentenaryInst Follow us (links open in a new window)

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Programs
  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram